Screener
Jazz Pharmaceuticals JAZZ Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Investments | 1,030.0 | 1,050.0 |
| Accounts receivable, net of allowances | 836.3 | 830.7 |
| Inventories | 437.5 | 417.0 |
| Prepaid expenses | 149.7 | 152.5 |
| Other current assets | 285.3 | 323.9 |
| Total current assets | 4,583.1 | 4,166.0 |
| Property, plant and equipment, net | 203.1 | 199.9 |
| Operating lease assets | 55.8 | 58.9 |
Item 1.Financial Statements
FAQ
- What is Jazz Pharmaceuticals's prepaid & other current?
- Jazz Pharmaceuticals (JAZZ) reported prepaid & other current of $149.7M in Q1 2026.
- How has Jazz Pharmaceuticals's prepaid & other current changed year-over-year?
- Jazz Pharmaceuticals's prepaid & other current decreased by 0.4% year-over-year, from $150.28M to $149.7M.
- What is the long-term trend for Jazz Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's prepaid & other current has grown at a 19.6% compound annual growth rate (CAGR), from $62.42M to $152.5M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Jazz Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude